The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2023 | Challenges and upcoming technologies in surgery for lung cancer
Alan Sihoe, MBBChir, FRCSEd, FCSHK, FHKAM, The University of Hong Kong, Pokfulam, Hong Kong, outlines the upcoming technologies and challenges in surgery for lung cancer management. In the last few years, major randomized trials have demonstrated that segmentectomy has a similar survival benefit to lobectomy which has been established as a standard of care surgery for lung cancer. As segmentectomy removes a smaller piece of the lung, the procedure is beneficial in preserving lung function and can also be recommended for patients who are usually ineligible for lobectomy, such as those with multifocal lung cancer. Dr Sihoe highlights that the current challenges in surgery include a lack of multidisciplinary collaboration, and in order to treat lung cancer effectively, multiple therapy modalities must be utilized. This interview took place at the 2023 World Conference on Lung Cancer (WCLC) in Singapore, Singapore.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
